Why Novavax Shares Are Falling
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower in sympathy with COVID-19 vaccine peer Moderna, which dipped after cutting its FY21 outlook.
Ominous Death Cross Forms On Novavax’s Chart
If history is any guide, there may be trouble ahead for shares of Novavax (NASDAQ:NVAX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
What’s Going On With Novavax Shares Today?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 14% at $196.43. The company and Serum Institute of India recently received Emergency Use authorization for a COVID-19 vaccine in Indonesia, with Novavax saying it expects other countries to make a decision within weeks.
64 Biggest Movers From Yesterday
Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
Technical Levels To Watch In Novavax Stock As It Looks To Bounce Back
Novavax Inc. (NASDAQ: NVAX) shares are trading higher Monday after the company completed its rolling submission to Health Canada for the authorization of its protein-based COVID-19 vaccine candidate.
Novavax was up 12.79% at $167.86 Monday afternoon.
Check Out What Whales Are Doing With NVAX
A whale with a lot of money to spend (and possibly insider knowledge) has taken a noticeably bearish stance on Novavax.
Looking at options history for Novavax (NASDAQ:NVAX) we detected 80 strange trades.